by Alex Kadhim
Researchers from a large multicenter collaboration, including the Center for International Blood and Marrow Transplant Research and several leading transplant institutions, have found that donor...
by Alex Kadhim
In a review, published in Current Opinion in Pharmacology, researchers from the University of California, Los Angeles and their collaborators highlight CD3⁺CD4⁻CD8⁻ double-negative T cells (DNTs)...
by Alex Kadhim
Researchers from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) conducted the PHYLOS trial and found that posttransplant cyclophosphamide (PTCy)-based prophylaxis significantly reduces the...
by Alex Kadhim
Researchers from the National Cancer Institute (NCI), USA, have demonstrated that intermediate-dose post-transplantation cyclophosphamide (ID-PTCy) at 25 mg/kg/day administered on days 3 and 4...
by Alex Kadhim
Researchers from Stanford University have demonstrated that administering precision-selected donor regulatory T-cell (Treg) therapy significantly improves graft-versus-host disease-free,...
by Alex Kadhim
Researchers from the University of Minnesota have demonstrated that individualized dosing of rabbit anti-thymocyte globulin (rATG), based on recipient bodyweight and absolute lymphocyte count...